Search results
Results from the WOW.Com Content Network
A 2016 Cochrane Review seeking to compare the effectiveness of various over the counter artificial tears in treating dry eye. While the review stated that it is unclear which artificial tear formulation works best, two trials found that 0.2% polyacrylic acid-based tears were more effective in treating dry eye symptoms over 1.4% polyvinyl ...
Eye drops are being recalled due to a rare bacterium found in artificial tears. Find a list of recalled drops in 2023. ... has issued yet another eye drop recall—this time focusing on 27 ...
The CDC says not to use EzriCare or Delsam Pharma's Artificial Tears as they've been linked to a drug-resistant strain of bacteria, which has led to 3 deaths. CDC warns not to use these eye drops ...
The FDA learned in January that the Pseudomonas aeruginosa outbreak was associated with EzriCare Artificial Tears. Over-the-counter eyedrops do not require FDA approval. Over-the-counter eyedrops ...
There is a wide variety of artificial tear eye drops that provide different surface healing strategies. One can find bicarbonate ions, hypotonicity, high viscosity gels and ointments, and non-preserved types. They all act differently and therefore, one may have to try different artificial tears to find the one that works the best. [3]
Perfluorohexyloctane is sold as an over-the-counter medication under the brand names Evotears and Novatears in multiple countries, [10] costing around NZ$34.00, A$30, and €30 for a one-month supply. In the US, perfluorohexyloctane is sold under the brand name Miebo; a prescription is required.
A rare bacterium found in artificial tears known is triggering eye drop recalls as investigators try to pinpoint the outbreak source. ... This recall includes over 700,000 bottles with expiration ...
Over time, it has been reported that many of the same drugs and eye drops used to treat particular eye diseases do, in fact, result in systemic side effects that could possibly be minimized or limited due to a slower, more sustained release of the drug.